Table 3.
Source | MHC restriction | Influence of IFN-γ | Sequence | Reference |
---|---|---|---|---|
▾ NAPIL STLPETTVVRRRGRSPR | ||||
HbcAg 141–151 | HLA-Aw68 | + | 14 | |
▿ RGVQI ASNENMD AMDSRTLELR | ||||
Influenza A NP | H2-Db | + | 35 | |
▾▾ LMY DM YPHFMPTNL GPSEKR | ||||
LCMV pp89 | H2-Ld | + | 8 | |
▾▿ KIM RTE RPQASGVYM GNLTAQ | ||||
LCMV NP | H2-Ld | + | 16 | |
▾ YKISKL VNIRNCCYI SGNGAE | ||||
Adeno E1B | H2-Kb | + | 13 | |
▾ TGSTAVPYGSF KHVDTRLQ | ||||
RUI | HLA-B51 | − | 20 |
aCleavages performed at comparable amounts by c20S and i20S proteasomes are not indicated. HBcAg, hepatitis B core antigen; ▾, i20S preference; ▿, c20S preference.